Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory de Lissovoy

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Chest|July 13, 2002
Management of acute proximal deep vein thrombosis: pharmacoeconomic evaluation of outpatient treatment with enoxaparin vs inpatient treatment with unfractionated heparinAlex C Spyropoulos, Judith S Hurley, Gabrielle N Ciesla, et al.
Journal of Child Neurology|July 5, 2007
Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsyGregory de Lissovoy, Louis S Matza, Hannah Green, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Increasing the use of arteriovenous fistula in hemodialysis: economic benefits and economic barriersDonald Schon, Steven W Blume, Kimberly Niebauer, et al.
The American Journal of Managed Care|March 13, 2008
Can managed care organizations partner with manufacturers for comparative effectiveness research?Bryan R Luce, L Clark Paramore, Bhash Parasuraman, et al.
The American Journal of Cardiology|August 29, 2003
Economic implications of nesiritide versus dobutamine in the treatment of patients with acutely decompensated congestive heart failureGregory de Lissovoy, David M Stier, Gabrielle Ciesla, et al.
American Journal of Infection Control|April 29, 2009
Surgical site infection: incidence and impact on hospital utilization and treatment costsGregory de Lissovoy, Kathy Fraeman, Valerie Hutchins, et al.
Journal of Medical Economics|November 26, 2011
Historical clinical and economic consequences of anemia management in patients with end-stage renal disease on dialysis using erythropoietin stimulating agents versus routine blood transfusions: a retrospective cost-effectiveness analysisHuseyin Naci, Gregory de Lissovoy, Christopher Hollenbeak, et al.
Archives of Internal Medicine|June 22, 2002
Willingness to pay for complete symptom relief of gastroesophageal reflux diseaseLeah Kleinman, Emma McIntosh, Mandy Ryan, et al.
Drugs & Aging|April 13, 2006
A taxonomy and economic consequences of nursing home fallsSonja V Sorensen, Gregory de Lissovoy, Dan Kunaprayoon, et al.
American Health & Drug Benefits|July 4, 2014
A value-based analysis of hemodynamic support strategies for high-risk heart failure patients undergoing a percutaneous coronary interventionDavid Gregory, Dennis J Scotti, Gregory de Lissovoy, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Chest|July 13, 2002
Management of acute proximal deep vein thrombosis: pharmacoeconomic evaluation of outpatient treatment with enoxaparin vs inpatient treatment with unfractionated heparinAlex C Spyropoulos, Judith S Hurley, Gabrielle N Ciesla, et al.
Journal of Child Neurology|July 5, 2007
Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsyGregory de Lissovoy, Louis S Matza, Hannah Green, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Increasing the use of arteriovenous fistula in hemodialysis: economic benefits and economic barriersDonald Schon, Steven W Blume, Kimberly Niebauer, et al.
The American Journal of Managed Care|March 13, 2008
Can managed care organizations partner with manufacturers for comparative effectiveness research?Bryan R Luce, L Clark Paramore, Bhash Parasuraman, et al.
The American Journal of Cardiology|August 29, 2003
Economic implications of nesiritide versus dobutamine in the treatment of patients with acutely decompensated congestive heart failureGregory de Lissovoy, David M Stier, Gabrielle Ciesla, et al.
American Journal of Infection Control|April 29, 2009
Surgical site infection: incidence and impact on hospital utilization and treatment costsGregory de Lissovoy, Kathy Fraeman, Valerie Hutchins, et al.
Journal of Medical Economics|November 26, 2011
Historical clinical and economic consequences of anemia management in patients with end-stage renal disease on dialysis using erythropoietin stimulating agents versus routine blood transfusions: a retrospective cost-effectiveness analysisHuseyin Naci, Gregory de Lissovoy, Christopher Hollenbeak, et al.
Archives of Internal Medicine|June 22, 2002
Willingness to pay for complete symptom relief of gastroesophageal reflux diseaseLeah Kleinman, Emma McIntosh, Mandy Ryan, et al.
Drugs & Aging|April 13, 2006
A taxonomy and economic consequences of nursing home fallsSonja V Sorensen, Gregory de Lissovoy, Dan Kunaprayoon, et al.
American Health & Drug Benefits|July 4, 2014
A value-based analysis of hemodynamic support strategies for high-risk heart failure patients undergoing a percutaneous coronary interventionDavid Gregory, Dennis J Scotti, Gregory de Lissovoy, et al.
Pageof 3